Efficient покрытие and Sterile Packaging Solutions for Transdermal Patches

How to Achieve Efficient покрытие and Sterile Packaging for Patch Products?

With the widespread application of transdermal patches, cooling patches, fever-reducing patches, and therapeutic patches in the фармацевтический and health sectors, manufacturers face two main challenges in production:

• How to achieve uniform покрытие of high-viscosity liquids?
• How to balance production efficiency with sterile требования for final packaging?

1. Efficient покрытие: Focus on “Control” and “Adaptability”

Patch formulations are usually high-viscosity systems containing volatile components, requiring precise покрытие uniformity and thickness control. Common issues include edge build-up, thinning in the middle, and bubble formation.

Solutions include:

• Adopting dual doctor blade or multi-roll покрытие systems to enhance leveling ability.
• Integrating automatic tension control systems to keep плёнка tension stable under high temperatures.
• Using enclosed circulation liquid supply systems to avoid air entry and control liquid temperature.
• Utilizing ducted airflow design to create a natural drying gradient, reducing shrinkage after покрытие.

The MJ150 ОРД растворитель-Based / трансдермальный пластырь плёнка Making машина supports continuous покрытие of viscous patch formulations, with покрытие thickness accuracy controlled within ±0.02 mm. For лаборатория or small-scale R&D, the MJ150-L ОРД плёнка покрытие машина offers similar precision with flexibility for тестирование environments.

2. Sterile Packaging: Balancing “Cleanliness” and “Production Pace”

Patch products are mostly for skin contact or external medical use, requiring specific cleanliness levels and ensuring no contaminants enter during packaging.

Recommended solutions include:

• Using enclosed cutting and transfer systems to avoid excessive exposure of the плёнка to air.
• Integrating HEPA-filtered hot air systems to reduce particle concentration in the packaging area.
• Combining vision inspection systems with automatic rejection devices to ensure defective patches are removed before final packaging.
• Installing laminar flow purification or ozone sterilization modules at the discharge point to enhance sterility assurance.

The MJF180 ОРД плёнка Cutting and Packaging машина can be equipped with cutting, vision inspection, automatic rejection, and edge-sealing modules, making it ideal for sterile packaging of medical patches and small-dose ОРД products.

Conclusion

The patch product market holds huge potential but places higher demands on process integration and cleanliness assurance. Only by ensuring “control” throughout the entire process—from raw liquid покрытие to final sterile packaging—can companies achieve standardized, efficient, and low-contamination production systems.

HUANGHAI provides end-to-end patch solutions from R&D and pilot тестирование to commercial-scale production, helping clients reduce trial-and-error costs and quickly enter the health and wellness market.

*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.

*Designed to meet Class I Div 1 / ATEX explosion-proof стандарты for safe transdermal растворитель handling.

---

Frequently Asked Questions

Q: What is the difference between an ОРД плёнка and a трансдермальный пластырь?

A: Oral Dissolving Films (ОРД) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar растворитель-cast плёнка покрытие processes. Huanghai's MJ150 ОРД машина supports both applications on a single platform with approximately 2 working days of changeover time.

Q: What production output can I expect from a Huanghai ОРД машина?

A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either машина with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.

Q: What drying technology does Huanghai use for ОРД production?

A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform плёнка thickness, reduced edge curl, and better АФИ distribution across the плёнка web. An optional far-infrared heating module adds 20–30% drying efficiency for растворитель-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ОРД оборудование supplier to Sinopharm, Shanghai фарма, and Fosun фарма.

Q: What are the GMP требования for ОРД production оборудование?

A: ОРД производство оборудование must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent стандарты (EU GMP Annex 1, ChGMP) for other markets. Key требования: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; данные integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ОРД машины meet these стандарты—all product contact surfaces use фармацевтический-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP соответствие documentation.

Q: Can Huanghai машины produce stripe-coated or multi-formula ОРД films?

A: Yes. Huanghai holds a patent for multi-formula stripe покрытие (Patent CN117323228A), enabling two different АФИ formulations to be applied side-by-side in a single покрытие pass. This eliminates the need for multiple покрытие/drying cycles when producing combination-drug ОРД products. Competitors require manual multi-layer покрытие with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-АФИ ODFs for cardiovascular or CNS indications) where покрытие efficiency directly impacts production economics.